We have located links that may give you full text access.
Comparative Study
Journal Article
[The effect of rilmenidine on the sympathetic activity of the renal nerve in waking barodenervated rats].
Eksperimental'naia i Klinicheskaia Farmakologiia 1993 November
The effects of intracisternal pretreatment with alpha 2-adrenoceptor antagonists which possess imidazoline (idazoxan) or nonimidazoline (yohimbine) structures on the sympatho-inhibitory action of rilmenidine were investigated in conscious sinoaortic denervated rats. Intracisternal injection of rilmendine significantly decreased renal sympathetic nerve activity. Idazoxan pretreatment prevented the sympathoinhibitory action of rilmenidine, whereas yohimbine pretreatment failed. It is concluded that the sympathoinhibitory action of rilmenidine relates more to the interaction with imidazoline receptors than alpha 2-adrenoceptors.
Full text links
Related Resources
Trending Papers
Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows.Endocrine Reviews 2024 April 28
The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association.Circulation 2024 April 26
Intravenous infusion of dexmedetomidine during the surgery to prevent postoperative delirium and postoperative cognitive dysfunction undergoing non-cardiac surgery: a meta-analysis of randomized controlled trials.European Journal of Medical Research 2024 April 19
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Management of Diverticulitis: A Review.JAMA Surgery 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app